TrialInternational journal of chronic obstructive pulmonary disease2022

Effect of Recent Exacerbation History on the Efficacy of Once-Daily Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Triple Therapy in Patients with Chronic Obstructive Pulmonary Disease in the FULFIL Trial.

Reynold A Panettieri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.